56
Participants
Start Date
April 30, 2007
Primary Completion Date
March 31, 2009
Study Completion Date
March 31, 2009
ADH-1
4 gm IV Days 1 and 8
melphalan
By Isolated Limb Infusion (ILI), Lower Extremity: 7.5 mg/L (Limb Volume), Day 1 or Upper Extremity: 10 mg/L (Limb Volume), Day 1
Lehigh Valley Hospital, Allentown
Duke University Medical Center, Durham
University of Florida College of Medicine, Gainesville
H. Lee Moffitt Cancer Center, Tampa
MD Anderson Cancer Center, Houston
University of Colorado, Denver, Aurora
Intermountain Medical Center, Murray
Lead Sponsor
Adherex Technologies, Inc.
INDUSTRY